Molecular and Cellular Biology, October 1998, p. 5621-5633, Vol. 18, No. 10
Massachusetts General Hospital Cancer Center,
Charlestown, Massachusetts 02129,1 and
The Children's Service, Massachusetts General Hospital,
Boston, Massachusetts 021142
Received 19 February 1998/Returned for modification 13 April
1998/Accepted 22 May 1998
Regulation of the mRNA cap binding protein (eIF4E) is critical to
the control of cellular proliferation since this protein is the
rate-limiting factor in translation initiation and transforms fibroblasts and since eIF4E mutants arrest budding yeast in the G1 phase of the cell cycle (cdc33). We
previously demonstrated regulation of eIF4E by altered transcription of
its mRNA in serum-stimulated fibroblasts and in response to
c-myc. To identify additional factors regulating eIF4E
transcription, we used linker-scanning constructs to characterize sites
in the promoter of the eIF4E gene required for its expression. Promoter
activity was dependent on sites at
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Novel Regulatory Factors Interacting with the
Promoter of the Gene Encoding the mRNA Cap Binding Protein (eIF4E) and
Their Function in Growth Regulation
5,
25,
45, and
75; the site
at
75 included a previously described myc box.
Electrophoretic mobility shift assays identified DNA-protein interactions at
25 and revealed a binding site (TTACCCCCCCTT) that is unique to the eIF4E promoter. Proteins of 68 and 97 kDa bound this site in UV cross-linking and Southwestern experiments. Levels of 4E regulatory factor activities correlated with c-Myc levels,
eIF4E expression levels, and protein synthesis in differentiating U937
and HL60 cells, suggesting that these activities may function to
regulate protein synthesis rates during differentiation. Since the
eIF4E promoter lacked typical TATA and initiator elements, further
studies of this novel initiator-homologous element should provide
insights into mechanisms of transcription initiation and growth
regulation.
*
Corresponding author. Mailing address: Massachusetts
General Hospital Cancer Center, Charlestown, MA 02129. Phone: (617)
726-5626. Fax: (617) 726-5637. E-mail:
Schmidt{at}HELIX.MGH.HARVARD.EDU.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|